U.S. markets open in 5 hours 33 minutes

LivaNova PLC (LIVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
53.34+2.31 (+4.53%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close51.03
Open51.00
Bid53.15 x 800
Ask53.32 x 800
Day's Range50.88 - 53.89
52 Week Range33.40 - 85.30
Volume665,195
Avg. Volume529,773
Market Cap2.592B
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-37% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • LivaNova PLC (NASDAQ:LIVN) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
    Simply Wall St.

    LivaNova PLC (NASDAQ:LIVN) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

    LivaNova PLC (NASDAQ:LIVN) shareholders are probably feeling a little disappointed, since its shares fell 5.8% to...

  • Benzinga

    Recap: LivaNova Q3 Earnings

    Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q3 results.Quarterly Results Earnings per share decreased 54.76% year over year to $0.38, which beat the estimate of $0.21.Revenue of $240,100,000 declined by 10.61% year over year, which beat the estimate of $218,550,000.Outlook The upcoming fiscal year's EPS expected to be between $1.15 and $1.35.The upcoming fiscal year's revenue expected to be between $900,000,000 and $1,008,000,000.How To Listen To The Conference Call Date: Oct 29, 2020View more earnings on LIVNTime: 08:00 AMET Webcast URL: https://edge.media-server.com/mmc/p/ra82i375Technicals Company's 52-week high was at $85.3052-week low: $33.40Price action over last quarter: Up 0.73%Company Description U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.See more from Benzinga * Click here for options trades from Benzinga * Recap: Janus Henderson Q3 Earnings * Brunswick: Q3 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • LivaNova (LIVN) Beats Q3 Earnings and Revenue Estimates
    Zacks

    LivaNova (LIVN) Beats Q3 Earnings and Revenue Estimates

    LivaNova (LIVN) delivered earnings and revenue surprises of 80.95% and 8.29%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?